Our Team
We’re attacking the big questions of longevity.
Juvenescence leverages a world-class team and technology to explore aging, cell regeneration, and age-related diseases and conditions.
Our Leadership
Juvenescence is composed of diverse minds that bring years of scientific, research and pharmaceutical industry experience to the table.
Dr. Greg Bailey, MD
Chief Executive Officer, Juvenescence
Jim Mellon
Chairman, Juvenescence
Dr. Declan Doogan, MD
Chief Medical Officer, Juvenescence
Dr. David Roblin, MBBS FMedSci
Chief Operating Officer, Juvenescence
David Ellam
Chief Financial Officer, Juvenescence
Colin Watts
Chief Executive Officer, Juvenescence Life
Alexander Pickett
Managing Director, Juvenescence
Dr. Ellen Donnelly, PhD
CEO, Epigenetics Division, Juvenescence
Dr. Margaret Jackson, DPhil
Head of Preclinical R&D, Juvenescence
Dr. Steve Felstead, MBChB
Head of Development Projects, Juvenescence
Dr. Nafees Malik, MBChB, MPhil
Head of Cell & Gene Therapy, Juvenescence
